ACCESS trial results at the 2026 Tandem Meetings reinforce mismatched unrelated donors as safe, effective and well-tolerated ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Patient Integration is increasingly urgent in oncology research, as growing complexity fuels demand for patient-level translation and outcomes that reflect real needs across preclinical and clinical ...

A geriatric oncology example shows how different analytic choices for longitudinal patient-reported outcomes can shift ...

Evaluating quality of life (QOL) in patients with idiopathic pulmonary fibrosis (IPF) goes beyond lung function numbers. It also shows how treatments affect daily well-being and guides funding, ...

WEST PALM BEACH, Fla. — Patient-reported outcomes (PROs) define the issues that matter to the patient, but their potential in multiple sclerosis (MS) is likely to remain unfulfilled until barriers, ...

The trial plans to enrol around 700 adults with CIC, with the primary endpoint assessing patient-reported constipation ...

Cutaneous sarcoidosis occurs in between 20% and 35% of systemic sarcoidosis patients and there is no approved therapy.

In this free webinar, learn how assessing cardiac safety risks of a new oncologic agent in early-phase clinical trials can be achieved with minimal impact on development cost and complexity. Attendees ...